Economy

High cholesterol, millions of Italians are at risk without knowing it: the values ​​to check to avoid heart attack and stroke

40.7% of Italians with high cholesterol don’t know they have it. Another 35.5% are aware of it, but do not follow any therapy. Only 23.8% are under treatment and, even among those taking drugs, less than two out of ten patients manage to reach the recommended values. This is the picture that emerges from the data of the Higher Institute of Health, relaunched on the occasion of the presentation to the Chamber of Deputies ofAgenda 2026-2030 for the management of dyslipidemia and the reduction of cardiovascular risk. Numbers that bring attention to one of the main risk factors for heart attack and stroke, often underestimated precisely because it does not cause obvious symptoms.

The problem affects over a quarter of the Italian population between 35 and 74 years of age and cannot be considered an issue exclusively linked to ageing. Even young, apparently healthy people without particular ailments can have high levels of LDL cholesterol, the one commonly defined as “bad”. The consequence is that cardiovascular risk can increase over the years without the person being aware of it.

High cholesterol, because it is dangerous even when there are no symptoms

Cholesterol is an essential substance for the body, involved in the formation of cell membranes and in the production of some hormones. The problem arises when the concentration of some lipoproteins in the blood, particularly low-density lipoproteins or LDL, exceeds the levels appropriate for the individual risk.

An excess of LDL cholesterol favors the accumulation of lipid material in the walls of the arteries, contributing to the formation of atherosclerotic plaques. Over time, these can narrow blood vessels, impede circulation and, in the most serious cases, break, encouraging the formation of clots responsible for heart attacks and strokes.

The most insidious feature is precisely the absence of recognizable signals. High cholesterol, in most cases, does not cause specific symptoms and can remain elevated for years before it is detected through a blood test.

The risk does not depend only on the single value, but also on its persistence over time and on the presence of other factors, such as hypertension, diabetes, smoking, family history of cardiovascular diseases and sedentary lifestyle.

The seriousness of the problem is also confirmed by the data on cardiovascular diseases in Italy, which are responsible for almost 225 thousand deaths and over 930 thousand hospital admissions every year. According to estimates from the National Association of hospital cardiologists, approximately 47 thousand deaths per year are attributable to insufficient cholesterol control.

What are the cholesterol values ​​to check

One of the most common mistakes is considering total cholesterol as the only indicator of cardiovascular health. In reality, to correctly assess the risk it is necessary above all to observe the LDL cholesteroltogether with HDL cholesterol, triglycerides and other elements of the clinical profile.

The guidelines of the European Society of Cardiology and the European Society of Atherosclerosis, updated in 2025, establish different objectives based on individual cardiovascular risk.

For people considered to be at low risk, the reference value for LDL cholesterol is less than 116 mg/dLwhile for those at moderate risk the target drops below 100 mg/dL.

The thresholds become more stringent for those with clinical conditions that increase the likelihood of developing cardiovascular disease. In high-risk patients, LDL cholesterol should be maintained below 70 mg/dLwhile for those at very high risk the target is less than 55 mg/dL. In these last two categories the recommendations generally also include a reduction of at least 50% compared to the initial values.

There is therefore no single number that is valid for everyone. A value considered acceptable for a young person without particular risk factors could be too high for someone who has already had a heart attack, suffers from certain chronic pathologies or has established cardiovascular disease.

For this reason, the result of the analyzes must be interpreted by the doctor in the context of the individual clinical situation, without limiting himself to checking whether the value falls within the range reported by the laboratory.

Because many Italians are unable to lower their cholesterol

The problem, according to experts, does not just concern the lack of diagnosis. Even when high cholesterol is identified and therapy is prescribed, achieving recommended values ​​often remains difficult.

Among the patients treated, just the 19.4% reach their therapeutic goal. A fact that highlights the distance between the possibilities offered by medicine and the results obtained in daily practice.

The reasons can be different: treatments that are not sufficiently intensive compared to the individual risk, checks that are spaced too far apart, difficulties in regularly following prescriptions and autonomous suspensions of drugs.

A particularly delicate aspect concerns statins, among the medicines most used to reduce LDL cholesterol. Although their effectiveness in cardiovascular prevention is documented by numerous studies, some patients continue to be wary of these treatments, sometimes preferring to resort to supplements.

Filippo Crea, president-elect of the European Society of Cardiology, drew attention to the so-called statin-phobiaunderlining how the failure to use effective therapies contributes to keeping cardiovascular risk high.

The most recent European recommendations confirm statins as the first pharmacological choice when indicated and provide, in necessary cases, the use of other therapies or drug combinations to achieve the established objectives. Supplements without adequate evidence of effectiveness are not an equivalent alternative to prescribed treatments.

The strategy that could save 3.7 billion euros

Improving cholesterol control would not only mean reducing heart attacks and strokes, but also reducing an important part of Italian healthcare spending.

This is the goal of CardioTarget – LDL Observatory for Cardiovascular Healthwhich on 16 November presented the 2026-2030 Agenda to the Chamber of Deputies, drawn up by a multidisciplinary group of 24 experts.

According to the estimates illustrated during the presentation, bringing patients to the recommended LDL cholesterol values ​​for their risk level could generate a potential saving of 3.7 billion euros of direct healthcare spending. A figure that should be considered as the estimated result of a more effective prevention strategy, not as a saving already achieved.

Cardiovascular diseases currently entail direct healthcare costs estimated at approximately 21.3 billion euros. The cost of a patient who does not reach the recommended therapeutic values ​​can reach, according to the evaluations presented, up to 2 thousand euros more.

The strategy therefore aims to intervene before complications appear, through timely diagnoses, periodic checks, appropriate treatments and greater continuity of care.

The goal is not simply to increase the number of people taking drugs, but to ensure that each patient achieves and maintains cholesterol levels appropriate to their condition over time.

How to lower cholesterol and when to get tested

Prevention begins with knowing your values. A simple blood test allows you to measure total, LDL and HDL cholesterol, along with triglycerides, offering the doctor the information necessary for an initial evaluation.

The frequency of checks is not the same for everyone. Those with a family history of high cholesterol or early cardiovascular disease, diabetes, hypertension or other risk factors may need closer checks than a person without particular clinical conditions.

Lifestyle also plays an important role. A balanced diet, with a limited consumption of saturated fats and a greater presence of fibre, legumes, whole grains, fruit and vegetables, can help reduce LDL cholesterol. Regular physical activity, weight control and avoiding smoking also help reduce overall cardiovascular risk.

When these measures are not sufficient, or when the cardiovascular risk is already high, it may be necessary to resort to drug therapy. However, any improvement in values ​​must not lead to the suspension of the medicines independently, because the treatment itself could be responsible for the result obtained.

From the November 23, 2026 free prevention days are also planned in Lombardy and Campania, identified as the first regions involved in the CardioTarget project.

The data on which specialists invite us to reflect remains the most significant: the majority of people with high cholesterol do not receive treatment and, among those who are treated, only a minority reach the recommended values. Knowing your LDL cholesterol, and above all knowing what your goal should be, represents one of the fundamental steps to reduce a risk that often develops without giving any signal.